EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Model construction and thrombolytic treatment of rat portal vein thrombosis

Zixiang Wang iD, Chenguang Su, Zheng Liao, Zixin Li, Jianli Wang, Shijie Fu, Jian Li, Jinlong Liu iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0308178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Zixiang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China. Hauptthemen laut MEDLINE: Portal Vein, Venous Thrombosis, Disease Models, Animal, Urokinase-Type Plasminogen Activator. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Key R&D Technology Project Health Innovation Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To construct a stable rat portal vein thrombosis (PVT) model and explore the time window of urokinase thrombolytic therapy on this basis.

Methods

Constructing a rat PVT model by combining anhydrous ethanol disruption of portal endothelium with stasis of blood flow. Forty-eight rats after PVT modeling were divided into control group and experimental group, with 24 rats in each group. The experimental and control groups were given urokinase treatment and saline tail vein injection, respectively. The two groups of rats were observed and compared for PVT formation at 1, 3 and 5 days after modeling, respectively.

Results

A stable rat PVT model was successfully constructed. No significant differences were found in PVT length, portal vein wet weight, and percentage of luminal occlusion area in the control rats at 1, 3, and 5 days after successful modeling (P > 0.05). Compared with control rats 1 day after modeling, the percentage of non-organized thrombus luminal area was significantly decreased (P < 0.0001), and the percentage of organized thrombus luminal area was significantly increased (P < 0.0001) in the PVTs of control rats at 3 and 5 days after modeling. After thrombolytic treatment with urokinase, plasma fibrinogen (FBG) levels were significantly decreased in the experimental group of rats compared with the control group (P < 0.0001), and plasma D-dimer (D2D) levels were significantly increased in the experimental group of rats compared with the control group (P < 0.0001). In addition, we observed prolongation of prothrombin time (PT) in the experimental group at 1, 3 and 5 days after modeling compared to the control group (P = 0.0001). Compared with the control group, portal vein wet weight and PVT length were significantly decreased in the experimental group of rats at 1 day after modeling (P < 0.05), whereas these differences were not found in the two groups of rats at 3 and 5 days after modeling (P > 0.05). The percentage of non-organized thrombus area in the experimental group was significantly decreased compared with that in the control group at 1, 3, and 5 days after modeling (P < 0.05), whereas there was no significant difference in the percentage of lumen area of organized thrombus between the two groups (P > 0.05).

Conclusion

The method of producing a rat PVT model by destroying the endothelium of the portal vein by anhydrous ethanol combined with blood flow stasis is feasible and reproducible. In addition, the optimal time window for thrombolysis in the treatment of PVT in rats using urokinase is the early stage of thrombosis, when the fibrin content is highest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Portal VeinVenous ThrombosisDisease Models, AnimalUrokinase-Type Plasminogen ActivatorThrombolytic TherapyAnimalsRatsMaleRats, Sprague-DawleyFibrinolytic AgentsFibrinogenFibrin Fibrinogen Degradation Products

Substanzen

Urokinase-Type Plasminogen ActivatorFibrinolytic AgentsFibrinogenFibrin Fibrinogen Degradation Products

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China.
  • Department of Pathology, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China.
  • Department of Hand and Foot Surgery, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China.
  • Hebei Key Laboratory of Panvascular Diseases, Chengde, China.

ORCID-Profile: Zixiang Wang, Jinlong Liu

Förderung

  • Hebei Province Key R&D Technology Project Health Innovation Special Project

Zitieren

APA

Wang, Z., Su, C., Liao, Z., Li, Z., Wang, J., Fu, S., Li, J., & Liu, J. (2024). Model construction and thrombolytic treatment of rat portal vein thrombosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0308178

Vancouver

Wang Z, Su C, Liao Z, Li Z, Wang J, Fu S, et al. Model construction and thrombolytic treatment of rat portal vein thrombosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0308178

BibTeX
@article{Wang2024,
  author = {Wang, Zixiang and Su, Chenguang and Liao, Zheng and Li, Zixin and Wang, Jianli and Fu, Shijie and Li, Jian and Liu, Jinlong},
  title = {Model construction and thrombolytic treatment of rat portal vein thrombosis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0308178}
}
Kostenlos starten →